J. Quiroga et al. / Tetrahedron Letters 51 (2010) 4717–4719
4719
4. (a) Rahimizadeh, M.; Shiri, A.; Bakavoli, M. Chin. Chem. Lett. 2007, 18, 689–693;
(b) Rolandsgard, M.; Baldawi, S.; Sirbu, D.; Bjørnstad, V.; Rømming, C.;
Undheim, K. Tetrahedron 2005, 61, 4129–4140; (c) Arya, K.; Dandia, A. J.
Fluorine Chem. 2007, 128, 224–231.
mp 224–226 °C. 1H NMR CDCl3 400 MHz rt d: 1.42 (s, 9H, CH3, t-Bu), 2.36 (s,
3H, CH3), 2.80 (m, 4H, C(30)H2 and C(40)H2), 2.94 (s, 2H, H-4), 3.22 (s, 2H, H-5),
3.94 (s, 2H, N7–CH2), 7.09 (d, 2H, Ho, aryl J = 8.3 Hz), 7.14 (d, 2H, Hm, aryl,
J = 8.2 Hz), 7.19 (t, 1H, Hp, J = 7.5 Hz), 7.36 (t, 2H, Hm, J = 7.9 Hz), 7.72 (d, 2H, Ho,
J = 8.0 Hz). 13C NMR CDCl3 100 MHz rt d: 21.1 (CH3), 24.3 (C-4), 29.3 (CH3, t-
Bu), 33.4 (Cq, t-Bu), 35.3 (C-30 and C-40), 51.1 (C-6), 55.2 (N7–CH2), 55.5 (C-
5. Marti, C.; Carrei, E. M. Eur. J. Org. Chem. 2003, 2209–2219.
6. (a) Martins, M. A. P.; Frizzo, C. P.; Moreira, D. N.; Buriol, L.; Machado, P. Chem.
Rev. 2009, 109, 4140–4182; (b) Kappe, C. O. Angew. Chem., Int. Ed. 2004, 43,
6250–6284.
7. (a) Quiroga, J.; Trilleras, J.; Insuasty, B.; Abonía, R.; Nogueras, M.; Cobo, J.
Tetrahedron Lett. 2008, 49, 2689–2691; (b) Quiroga, J.; Trilleras, J.; Insuasty, B.;
Abonía, R.; Nogueras, M.; Marchal, A.; Cobo, J. Tetrahedron Lett. 2008, 49, 3257–
3259; (c) Quiroga, J.; Insuasty, B.; Insuasty, H.; Abonía, R.; Ortíz, A. J.; Sánchez,
A.; Nogueras, M. J. Heterocycl. Chem. 2001, 38, 339–341; (d) Quiroga, J.;
Hormaza, A.; Insuasty, B.; Ortíz, A. J.; Sánchez, A.; Nogueras, M. J. Heterocycl.
Chem. 1998, 35, 231–233.
8. (a) Quiroga, J.; Cruz, S.; Insuasty, B.; Abonía, R.; Hernandez, P.; Bolaños, A.;
Moreno, R. J. Heterocycl. Chem. 1998, 35, 333–338; (b) Orlov, V. D.; Quiroga, J.;
Kolos, N. N. Khim. Geterosikl. Soedin. 1987, 1247–1251. CA: 88, 167373; (c)
Quiroga, J.; Portilla, J.; Serrano, H.; Abonía, R.; Insuasty, B.; Nogueras, M.; Cobo,
J. Tetrahedron Lett. 2007, 48, 1987–1990; (d) Quiroga, J.; Cobo, D.; Insuasty, B.;
Abonía, R.; Cruz, S.; Nogueras, M.; Cobo, J. J. Heterocycl. Chem. 2008, 45, 155–
159; (e) Quiroga, J.; Trilleras, J.; Sánchez, A. I.; Insuasty, B.; Abonía, R.;
Nogueras, M.; Cobo, J. Lett. Org. Chem. 2009, 6, 381–383.
9. (a) Quiroga, J.; Cruz, S.; Insuasty, B.; Abonía, R.; Nogueras, M.; Cobo, J.
Tetrahedron Lett. 2006, 47, 27–30; (b) Low, J. N.; Cobo, J.; Mera, J.; Quiroga, J.;
Glidewell, C. Acta Crystallogr., Sect. C 2004, 60, 265–269; (c) Low, J. N.; Ferguson,
G.; Cobo, J.; Nogueras, M.; Cruz, S.; Quiroga, J.; Glidewell, C. Acta Crystallogr.,
Sect. C 2004, 60, 438–443.
5(10)), 99.2 (C-3a), 123.4 (Co), 126.6 (Cp), 128.0 (Co, aryl), 129.0 (Cm), 129.4 (Cm
,
aryl), 133.5 (Ci, aryl), 137.5 (Cp, aryl), 140.1 (Ci), 144.6 (C-7a), 157.4 (C-3), 213.4
(C@O). IR (KBr) cmꢁ1 2962 (CH st), 1713–1691 (C@O st). The mass spectrum
shows the following peaks: MS (70 eV) m/z (%) = 441 (M+, 100), 336 (29), 280
(86). HR-MS calcd for C28H31N3O2 441.2416, found 441.2419. Anal. Calcd for
C28H31N3O2: C, 74.08; H, 7.14; N, 9.26. Found: C, 73.96; H, 6.97; N, 9.37.
Data for 3-tert-butyl-1-phenyl-7-(4-methylbenzyl)-40,40-dimethyl-4,5,6,7-tetrahydro-
1H-pyrazolo[3,4-b]pyridine-5-spiro-10-cyclohexane-20,60-dione 5e. White crystalline
solid, 75%, mp 199–201 °C. 1H NMR CDCl3 400 MHz rt d: 0.86 (s, 3H, CH3), 1.06
(s, 3H, CH3), 1.41 (s, 9H, CH3, t-Bu), 2.33 (s, 3H, CH3), 2.45 (d, 2H, CH2
J = 14.0 Hz), 2.67 (d, 2H, CH2 J = 14.0 Hz), 3.15 (s, 2H, H-4), 3.35 (s, 2H, H-6),
3.82 (s, 2H, N7–CH2), 7.09–7.14 (m, 5H, Hp, 4H aryl), 7.29 (t, 2H, Hm, J = 7.5 Hz),
7.63 (d, 2H, Ho, J = 7.5 Hz). 13C NMR CDCl3 100 MHz rt d: 21.1 (CH3), 23.6 (C-4),
26.9 (CH3), 29.3 (CH3, t-Bu), 29.9 (CH3), 31.0 (C40), 33.3 (Cq, t-Bu), 51.9 (C30,
C50), 53.5 (C-6), 55.4 (N7–CH2), 64.3 (C-5(10)), 100.7 (C-3a), 123.4 (Co), 126.5
(Cp), 127.6 (Cm), 129.0 (Cm, aryl), 129.4 (Co, aryl), 133.5 (Cp, aryl), 137.4 (Ci, aryl),
140.2 (Ci), 144.0 (C-7a), 157.4 (C-3), 206.5 (C@O). IR (KBr) cmꢁ1 2961 (CH st),
1722–1690 (C@O st). The mass spectrum shows the following peaks: MS
(70 eV) m/z (%) = 483 (M+, 100), 378 (76), 322 (57), 276 (22), 252 (19). HR-MS
calcd for C31H37N3O2 483.2886, found 483.2894. Anal. Calcd for C31H37N3O2: C,
76.98; H, 7.71; N, 8.69. Found: C, 76.96; H, 7.69; N, 8.72.
Data for 3-tert-butyl-5-spiro-1-phenyl-7-(4-methylbenzyl)-1H-pyrazolo[3,4-
b]pyridine-4,5,6,7-tetrahydro-20-indan-10,30-dione 6a. After separating the
compound 7 in 45% yield. Pale yellow solid, 50%, mp 230–231 °C. 1H NMR
CDCl3 400 MHz rt d: 1.38 (s, 9H, CH3, t-Bu), 2.25 (s, 3H, CH3), 3.06 (s, 2H, H-4),
3.33 (s, 2H, H-5), 4.07 (s, 2H, N7–CH2), 7.00 (s, 4H, Ho, Hm, aryl), 7.17 (t, 1H, Hp,
J = 7.5 Hz), 7.33 (t, 2H, Hm, J = 7.9 Hz), 7.75 (d, 2H, Ho, J = 7.5 Hz), 7.84–7.86 (m,
2H, H-50, H-60), 7.96–7.98 (m, 2H, H-40, H-70). 13C NMR CDCl3 100 MHz rt d:
21.0 (CH3), 26.0 (C-4), 29.30 (CH3, t-Bu), 33.3 (Cq, t-Bu), 50.8 (C-5(20)), 50.9 (C-
6) 55.4 (N7–CH2), 98.7 (C-3a), 123.4 (C-40 and C-70), 123.6 (Co), 126.5 (Cp),
127.9 (Cm, aryl), 129.0 (Cm), 129.1 (Co, aryl), 133.9 (Ci, aryl), 135.8 (C-50 and C-
60), 136.9 (Cp, aryl), 140.4 (Ci), 141.0 (C-30 and C-10), 145.4 (C-7a), 157.4 (C-3),
202.1(C@O). IR (KBr) cmꢁ1 2963 (CH st), 1721–1700 (C@O st). The mass
spectrum shows the following peaks: MS (70 eV) m/z (%) = 489 (M+, 100), 328
(90), 384 (19). HR-MS calcd for C32H31N3O2 489.2416, found 489.2426. Anal.
Calcd for C32H31N3O2: C, 77.66; H, 6.27; N, 8.49. Found C, 77.21; H, 6.43; N,
8.67.
Data for 3-tert-butyl-1-phenyl-1H-indeno[2,3-e]pyrazolo[3,4-b]pyridine-5-one 7.
The product was separated by silica gel chromatography eluting with
chloroform. Yellow solid, 45%, mp 192–194 °C. 1H NMR CDCl3 400 MHz rt d:
1.56 (s, 9H, CH3, t-Bu), 7.33 (t, 1H, Hp, J = 7.3 Hz), 7.47 (t, 1H, H-7, J = 7.5 Hz),
7.54 (t, 2H, Hm, aryl, J = 7.5 Hz), 7.76 (d, 2H, Ho, J = 7.3 Hz), 7.62 (t, 1H, H-8,
J = 7.5 Hz), 7.97 (d, 1H, H-6, J = 7.5 Hz), 8.34 (d, 1H, H-9, J = 8.0 Hz), 8.45 (s, 2H,
H-4). 13C NMR CDCl3 100 MHz rt d: 29.9 (CH3), 34.4 (Cq, t-Bu), 114.5 (C-3a),
121.5 (C-9), 121.6 (C-6), 123.9 (Co), 126.2 (Cp), 127.7 (C-4), 129.0 (Cm), 131.4 (C-
7), 135.0 (C-8), 137.3 (C-5a), 139.2 (Ci), 143.1 (C-9a), 153.6 (C-10a), 156.7 (C3),
164.1 (C-9b), 190.9 (C@O). IR (KBr) cmꢁ1 2963 (CH st), 1715 (C@O st). The mass
spectrum shows the following peaks: MS (70 eV) m/z (%) = 353 (M+, 39), 339
(22), 338 (100). HR-MS calcd for C23H19N3O 353.1528, found 353.1529. Anal.
Calcd for C23H19N3O: C, 78.16; H, 5.42; N, 11.89. Found: C, 78.10; H, 5.48; N,
11.90.
10. Castillo, J. C.; Abonía, R.; Cobo, J.; Glidewell, C. Acta Crystallogr., Sect. C 2009, 65,
303–310.
11. (a) Trilleras, J.; Cruz, S.; Cobo, J.; Low, J. N.; Glidewell, C. Acta Crystallogr., Sect. C
2008, 64, 671–674; (b) Trilleras, J.; Quiroga, J.; Cobo, J.; Low, J. N.; Glidewell, C.
Acta Crystallogr., Sect. C 2008, 64, 665–670; (c) Cruz, S.; Trilleras, J.; Cobo, J.; Low, J.
N.; Glidewell, C. Acta Crystallogr., Sect. C 2008, C64, 637–642; (d) General procedure
to the synthesis of pyrazolopyridine–5–spiro derivatives 4, 5 and 6. Microwave
method: Microwave experiment was carried out using a focused microwave
reactor (CEM Discover TM). A mixture of amine (2 mmol), cyclic b-diketone
(2 mmol
of
5,5-dimethylcyclohexane-1,3-dione,
cyclohexane-1,3-dione,
cyclopentane-1,3-dione or indandione) and an excess of paraformaldehyde
(30 mol %) was exposed to microwave radiation for 25 min at 200 °C and a
maximum power of 300 W. The reaction mixture was dissolved in hot ethanol.
After cooling down to room temperature, the solid product was filtered and
washed with fresh ethanol and hexanes (2 ꢀ 5 mL) to afford a pure product.
Conventional method: A solution of amine (2 mmol), cyclic b-diketone (2 mmol of
5,5-dimethylcyclohexane-1,3-dione, cyclohexane-1,3-dione, cyclopentane-1,3-
dione or indandione) in ethanol (15 mL), was added to an excess of
paraformaldehyde (30 mol %) and the mixture was heated under reflux for
24 h. After cooling down to rt, the colourless precipitate was filtered off, washed
with ethanol (2 ꢀ 5 mL) and dried to afford the pure products. In the case of the
reaction between indandione and all 5-aminopyrazoles derivatives 1, the
compound 7 was obtained in a yield of 45% in each reaction after separating by
column chromatography using chloroform as the eluent.
12. Simon, C.; Constantieux, T.; Rodriguez, J. Eur. J. Org. Chem. 2004, 4957–4980.
13. All new compounds gave satisfactory 400 MHz 1H NMR and 100 MHz 13C NMR
and IR spectral data.
Selected physical data.
Data for 3-tert-butyl-5-spiro-1-phenyl-7-(4-methylbenzyl)-1H-pyrazolo[3,4-
b]pyridine-4,5,6,7-tetrahydro-10-cyclopentano-2,5-dione 4a. White solid, 84%,